[ad_1]
DALLAS, Texas, Oct. 25, 2022 (GLOBE NEWSWIRE) — The use of stem cells to treat a variety of animal diseases and injuries animal stem cell therapy, a new and developing field of veterinary medicine. Unspecialized cells called animal stem cells have the ability to differentiate into all types of body tissues. As a result, it can be used to treat a wide variety of diseases and conditions, including diabetes, kidney disease, cardiovascular disease, osteoarthritis, ligament and tendon fractures, and arthritic ailments. The appetite for animal stem cell therapies is driven by two factors: the growing public awareness of animal health issues and the rising cost of conventional veterinary medicine. The demand for animal stem cell therapy is expected to increase as more people become aware of its benefits. The availability of this novel therapy is also increasing as a result of technological developments that allow the isolation and expansion of animal stem cells.
Animal stem cell therapy market growth is projected to intensify at a CAGR of 4.9% from 2022 to 2032. As a result, the market value will reach US$425.1 million by the end of 2032.
Growing demand for pet insurance, increased public awareness of animal health issues, and technological advances are just some of the factors driving this expansion.
Request a sample copy of our research report: https://www.adroitmarketresearch.com/contacts/request-sample/3493
The major players operating in the global animal stem cell therapy market are:
Vetstem Biopharma
Serabet Co., Ltd.
Kintaro Cell Power
Magellan stem cells
united stem cells
sells power japan
J-arm
animal care stem
cell therapy science
VetCell Therapeutics
There are two main types of animal stem cell therapy: allogeneic and autologous. In contrast to autologous therapy, which uses the animal’s own stem cells, allogeneic therapy uses stem cells from different members of the same species. Allogeneic therapy is used more frequently in veterinary medicine because it is easier to obtain stem cells from another animal than from the patient.
This industry is centered on companies that analyze and create items that utilize animal stem cell therapy. This group includes VCA, Zoetis, Ceva Sante Animale, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Merck Animal Health. These companies are dedicated to creating new and enhanced animal stem cell therapies that can be applied to treat a variety of animal diseases. These companies also participate in marketing campaigns to educate consumers and health professionals about the benefits of animal stem cell therapy.
The market for equine stem cell therapy is likely to grow as a result of the popularity of equestrian sports and the increase in horse owners. The availability of new and better stem cell therapy products and growing awareness of the potential benefits of equine stem cell therapy are further drivers of the market. The expansion of this business is also being fueled by an increasing number of horse owners who are ready to invest in the health and well-being of their animals.
>>>Purchase the research report here@ https://www.adroitmarketresearch.com/researchreport/purchase/3493
The veterinary hospital sector is projected to expand at the largest CAGR among end users during the forecast period. This expansion has been attributed both to an increase in pet owners and a growing understanding of animal health. The latest technology is also available in veterinary facilities, and our staff members are skilled and qualified to provide animal stem cell therapy and other treatments.
Asia-Pacific is expected to experience the fastest growth rate in the animal stem cell therapy market during the forecast period. Increased demand for pet insurance, increased public awareness of animal health issues, and improved technology have all contributed to the growth of the region. In addition, the region has a large number of veterinarians and pet owners, which has accelerated the expansion of this sector.
VetStem Biopharma Inc., a US-based provider of animal stem cell therapy products, declared in May 2019 that its new product, VetStem Regenerative cells, was approved by the FDA. This item is made to treat arthritis in dogs.
A partnership to establish a stem cell research facility in Tianjin, China, was signed in March 2019 by the Chinese company Boyalife Group and the Tianjin International Joint Academy of Biotech and Pharmacy. The study of stem cell applications in both humans and animals is the aim of the research institute.
The FDA approved a new drug, VetStem Plus, in February 2019, according to Swiss company Emcyte Corporation. This item is made to treat arthritis in dogs.
table of contents:
1.First of all
2. Survey method
3. Market Outlook
4. Animal Stem Cell Therapy Market by Application, 2022-2029 (Million USD)
4.1. Cats
4.2. Horses
4.3. Dogs
4.4. Miscellaneous
5. Animal Stem Cell Therapy Market by End-User, 2022-2029 (Million USD)
5.1. Animal Hospital
5.2. Animal Hospital
5.3. Research Institutions
6. Animal Stem Cell Therapy Market by Regions from 2022 to 2029 (USD Million)
6.1. North America
6.1.1. We
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. Germany
6.2.3. France
6.2.4. Rest of Europe
6.3. Asia Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia Pacific
6.4. South America
6.4.1. Brazil
6.4.2. Mexico
6.4.3. Rest of South America
6.5. Middle East and Africa
7. Competitive environment
8. Company profile
9. Appendix
Get discount on this report: https://www.adroitmarketresearch.com/contacts/discount/3493
Visit Research Repository for Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html
about us:
Adroit Market Research is an India-based business analytics and consulting company founded in 2018. Our target audience is a wide range of companies, manufacturers, product/technology development organizations and trade associations who need an understanding of market size, key trends and participants. and future prospects for the industry. We aim to be our clients’ knowledge partner, providing them with valuable market insights and creating opportunities to increase their revenue. Follow the code of Explore, Learn, Transform. At our core, we are curious people who love to identify and understand industry patterns, create insightful research on findings, and create roadmaps for making money.
inquiry:
Ryan Johnson
Account Manager – Global
3131 McKinney Ave Ste 600
Dallas, Texas 75204
Email ID: sales@adroitmarketresearch.com
Phone: +1-9726644514, +91-9665341414
Connect with us: Facebook | | twitter | | LinkedIn
[ad_2]
Source link